
A developer of therapies produced with synthetic biology for diseases linked to microbes in the gut is raising $15 million in seed financing. . . . → Read More: Synthetic Bio Microbiome Biotech Gains $15M in Seed Funds
|
|||||
![]() A developer of therapies produced with synthetic biology for diseases linked to microbes in the gut is raising $15 million in seed financing. . . . → Read More: Synthetic Bio Microbiome Biotech Gains $15M in Seed Funds ![]() A start-up company designing and testing precise proteins within live animals to speed creation of new therapeutics is raising $40 million in its first venture round. . . . → Read More: Precision Protein Design Start-Up Gains $40M in Early Funds ![]() Two biotechnology companies are advancing basic research findings connecting gut microbes with the brain to develop new therapies for neurological disorders. . . . → Read More: Biotechs Explore Gut-Brain Axis for Mental Health ![]() A clinical trial is underway evaluating a precise form of Crispr gene editing as a one-time therapy for an inherited form of heart disease. . . . → Read More: Trial Begins of Precise Gene Editing for Heart Disease ![]() A developer of therapies derived from stem cells to replace malfunctioning islet cells in people with type 1 diabetes was acquired by Vertex Pharmaceuticals. . . . → Read More: Diabetes Cell Therapy Biotech Acquired in $320M Deal ![]() Researchers analyzed medical and scientific databases with algorithms to identify eight previously unreported biomarkers contributing to neurodegeneration similar to ALS. . . . → Read More: AI Analytics Find New ALS Genetic Drug Targets ![]() A study shows implanted lab-grown pieces of human 3-D kidney tissue can demonstrate chemical activity of drugs in preclinical tests with lab rats. . . . → Read More: Human Organoids Show Drug Activity in Lab Animals ![]() Biotech, pharma, and diagnostics companies are forming a new business to design precision diagnostics and treatments for drug-resistant microbes. . . . → Read More: Precision Microbial Resistance Joint Venture Formed ![]() A start-up company developing nutritional therapies to attack precise molecular cancer targets is raising $47 million in its first venture funding round. . . . → Read More: Cancer Nutrition Therapy Biotech Raises $47M in Early Funds ![]() The Food and Drug Administration published its blueprint to encourage new treatments for rare neurodegenerative disorders, including ALS. . . . → Read More: FDA Issues Action Plan for Rare Neuro Diseases |
|||||
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |